Current Interventions Fail to Reduce Benzodiazepine Use in Older Adults
HCPLive
NOVEMBER 2, 2024
Neither clinician peer comparison nor patient informational mail reduced benzodiazepine use among older adults in anesthesia care, a new study finds.
Sat.Nov 02, 2024
105 
Can a mammogram identify heart disease risk?
Medical Xpress - Cardiology
NOVEMBER 2, 2024
When people check in for their annual mammogram these days, some may face a surprising question: In addition to reviewing the mammogram for breast cancer, would the patient like the radiologist to examine the images for heart disease risk?
Implications of Findings on Patient-Reported Outcomes for Roflumilast Foam, with Melinda Gooderham, MD
HCPLive
NOVEMBER 2, 2024
This interview from Fall Clinical highlights the broader implications of the phase 3 data resulting from the ARRECTOR trial on roflumilast foam for those with psoriasis.
I am qualified , yet not good enough to practice medicine
Dr. S. Venkatesan MD
NOVEMBER 2, 2024
Visit the post for more.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
FDA Committee Casts Negative Vote on Sotagliflozin in Type 1 Diabetes
HCPLive
NOVEMBER 2, 2024
The 11 to 3 vote against the benefit-risk profile of sotagliflozin comes with less than 2 months to go until the December 20, 2024 PDUFA date.
Expert explains cardiac amyloidosis
Medical Xpress - Cardiology
NOVEMBER 2, 2024
Cardiac amyloidosis is a rare condition defined by the abnormal production of proteins that bind together to form amyloid proteins. These amyloids can gather in different organs throughout the body, including the heart, liver and kidneys. When amyloids form in the heart, the condition is referred to as cardiac amyloidosis.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Tailored Therapy in Cardiogenic Shock: Case-Based Management Choices
The American Journal of Cardiology
NOVEMBER 2, 2024
Publication date: Available online 1 November 2024 Source: The American Journal of Cardiology Author(s): S. Shiva Patlolla, Amit H. Alam, Jason N. Katz, Shelley A.
Important findings for patients with previous coronary intervention for de novo and in-stent restenosis indications: a novel use of randomized trial data
The American Journal of Cardiology
NOVEMBER 2, 2024
Publication date: Available online 1 November 2024 Source: The American Journal of Cardiology Author(s): Charles Maynard
Let's personalize your content